Abercrombie George B
SEC-identified person · CIK 1485939 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biocryst Pharmaceuticals INC BCRX | Director | filed 2011 - 2024 |
| Vical INC VICl | Director · CHIEF EXECUTIVE OFFICER | filed 2019 - 2020 |
| Theravance INC thrx | Sr. VP, Corp. Partnerships | filed 2014 - 2018 |
| Tranzyme INC TZYM | Director | filed 2011 - 2012 |
| Inspire Pharmaceuticals INC ISPH | Director | filed 2010 - 2011 |
| Ziopharm Oncology INC ZIOP | Director | filed 2010 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.